Literature DB >> 9474196

The correlation of urodynamic findings with cranial magnetic resonance imaging findings in multiple sclerosis.

Y H Kim1, C Goodman, E Omessi, V Rivera, M W Kattan, T B Boone.   

Abstract

PURPOSE: To our knowledge there are no studies of the correlation between urinary complaints or urodynamic findings in multiple sclerosis and magnetic resonance imaging (MRI) findings. We investigated the correlation of urodynamic results in multiple sclerosis patients with voiding complaints to the cranial MRI findings. We also sought to correlate urodynamic results in these patients with International Prostate Symptom Scores (IPSS).
MATERIALS AND METHODS: We retrospectively reviewed urodynamic results and cranial MRI findings in 90 multiple sclerosis patients (64 women, 26 men, mean age 44.5 years) with voiding complaints. The most recent urodynamic study and cranial MRI for each patient were reviewed. The interval between the 2 studies and MRI was no more than 6 months. Detrusor contractions were categorized as areflexic, hyporeflexic, hyperreflexic or hyperreflexic with impaired contractility. The presence of impaired compliance or detrusor-external sphincter dyssynergia was recorded. The cranial MRI findings were categorized on the basis of the presence of atrophy or enhancing lesions, total number of lesions and size of largest lesion. The urodynamic and MRI findings were correlated. Of the patients 40 who had urodynamic studies done within the last 6 months completed the IPSS, and severity of cranial MRI findings in these patients was correlated with the IPSS results. In addition, the presence of irritative findings of detrusor hyperreflexia or detrusor hyperreflexia with impaired contractility was correlated with the irritative score (sum of questions 1, 2, 4, 7), and the presence of detrusor-external sphincter dyssynergia was correlated with the obstructive score (sum of questions 3, 5, 6).
RESULTS: There was no correlation between urodynamic category, presence of impaired compliance or presence of detrusor-external sphincter dyssynergia and any of the MRI findings of atrophy or enhancing lesions, total number of lesions or size of the largest lesions. In the patients who completed the IPSS there was no correlation between total number of lesions and IPSS score. There was no correlation between the presence of detrusor-external sphincter dyssynergia and obstructive score on the IPSS or between the presence of detrusor hyperreflexia and irritative score.
CONCLUSIONS: Although patients with multiple sclerosis often are followed closely with urodynamic studies and cranial MRI, there appears to be no correlation between these 2 studies. Symptom scores also do not appear to correlate with urodynamic findings. Therefore, urodynamic studies appear to be warranted and irreplaceable in the evaluation of voiding dysfunction in multiple sclerosis patients.

Entities:  

Mesh:

Year:  1998        PMID: 9474196

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  Vesicourethral dysfunction in multiple sclerosis. Initial assessment based on lower urinary tract symptoms and their pathophysiology.

Authors:  Paolo Di Benedetto; Cristina Delneri; Emanuele Biasutti; Luisa Monti Bragadin; Tullio Giorgini
Journal:  Neurol Sci       Date:  2008-12       Impact factor: 3.307

Review 2.  Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.

Authors:  Oussama El Yazami Adli; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2014-01       Impact factor: 1.862

3.  Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients.

Authors:  P Gallien; J-M Reymann; G Amarenco; B Nicolas; M de Sèze; E Bellissant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

4.  Association between urinary symptom severity and white matter plaque distribution in women with multiple sclerosis.

Authors:  Ariana L Smith; Steven J Weissbart; Siobhán M Hartigan; Michel Bilello; Diane K Newman; Alan J Wein; Anna P Malykhina; Guray Erus; Yong Fan
Journal:  Neurourol Urodyn       Date:  2019-11-06       Impact factor: 2.696

5.  Similarity of functional connectivity patterns in patients with multiple sclerosis who void spontaneously versus patients with voiding dysfunction.

Authors:  Rose Khavari; Saba N Elias; Timothy Boone; Christof Karmonik
Journal:  Neurourol Urodyn       Date:  2018-10-12       Impact factor: 2.696

6.  Brain activation patterns of female multiple sclerosis patients with voiding dysfunction.

Authors:  Rose Khavari; Jessie Chen; Timothy Boone; Christof Karmonik
Journal:  Neurourol Urodyn       Date:  2020-02-07       Impact factor: 2.696

Review 7.  Contemporary concepts in the aetiopathogenesis of detrusor underactivity.

Authors:  Nadir I Osman; Christopher R Chapple
Journal:  Nat Rev Urol       Date:  2014-10-21       Impact factor: 14.432

8.  Bladder, Bowel, and Sexual Dysfunction in Multiple Sclerosis.

Authors:  Kathleen S. Hawker; Elliot M. Frohman
Journal:  Curr Treat Options Neurol       Date:  2001-05       Impact factor: 3.598

9.  Functional Magnetic Resonance Imaging with Concurrent Urodynamic Testing Identifies Brain Structures Involved in Micturition Cycle in Patients with Multiple Sclerosis.

Authors:  Rose Khavari; Christof Karmonik; Michael Shy; Sophie Fletcher; Timothy Boone
Journal:  J Urol       Date:  2016-09-21       Impact factor: 7.450

10.  The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis.

Authors:  Steven J Weissbart; Dasha Pechersky; Anna Malykhina; Thomas Bavaria; Lisa Parrillo; Lily A Arya; Michel Bilello; Alan J Wein; Ariana L Smith
Journal:  Neurourol Urodyn       Date:  2016-01-06       Impact factor: 2.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.